PLAYSTUDIOS INC (MYPS)

US72815G1085 - Common Stock

2.05  -0.02 (-0.97%)

After market: 2.05 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MYPS. MYPS was compared to 76 industry peers in the Entertainment industry. MYPS has a great financial health rating, but its profitability evaluates not so good. MYPS is not valued too expensively and it also shows a decent growth rate.



3

1. Profitability

1.1 Basic Checks

MYPS had negative earnings in the past year.
In the past year MYPS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: MYPS reported negative net income in multiple years.
Each year in the past 5 years MYPS had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -4.86%, MYPS is in line with its industry, outperforming 50.00% of the companies in the same industry.
MYPS has a Return On Equity of -6.03%. This is in the better half of the industry: MYPS outperforms 61.84% of its industry peers.
Industry RankSector Rank
ROA -4.86%
ROE -6.03%
ROIC N/A
ROA(3y)-2.38%
ROA(5y)3.21%
ROE(3y)-3.03%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

MYPS has a Gross Margin of 74.98%. This is amongst the best in the industry. MYPS outperforms 92.11% of its industry peers.
MYPS's Gross Margin has improved in the last couple of years.
MYPS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.29%
GM growth 5Y2.64%

8

2. Health

2.1 Basic Checks

MYPS does not have a ROIC to compare to the WACC, probably because it is not profitable.
MYPS has more shares outstanding than it did 1 year ago.
There is no outstanding debt for MYPS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

MYPS has an Altman-Z score of 3.65. This indicates that MYPS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.65, MYPS belongs to the top of the industry, outperforming 86.84% of the companies in the same industry.
There is no outstanding debt for MYPS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.65
ROIC/WACCN/A
WACC9%

2.3 Liquidity

A Current Ratio of 4.53 indicates that MYPS has no problem at all paying its short term obligations.
The Current ratio of MYPS (4.53) is better than 89.47% of its industry peers.
A Quick Ratio of 4.53 indicates that MYPS has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.53, MYPS belongs to the top of the industry, outperforming 89.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.53
Quick Ratio 4.53

4

3. Growth

3.1 Past

MYPS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -750.00%.
MYPS shows a small growth in Revenue. In the last year, the Revenue has grown by 2.87%.
The Revenue has been growing by 9.72% on average over the past years. This is quite good.
EPS 1Y (TTM)-750%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)2.87%
Revenue growth 3Y4.83%
Revenue growth 5Y9.72%
Sales Q2Q%-2.86%

3.2 Future

The Earnings Per Share is expected to grow by 34.22% on average over the next years. This is a very strong growth
Based on estimates for the next years, MYPS will show a small growth in Revenue. The Revenue will grow by 2.32% on average per year.
EPS Next Y116.59%
EPS Next 2Y55.79%
EPS Next 3Y34.22%
EPS Next 5YN/A
Revenue Next Year3.34%
Revenue Next 2Y3.69%
Revenue Next 3Y3.67%
Revenue Next 5Y2.32%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MYPS. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 32.00, MYPS can be considered very expensive at the moment.
64.47% of the companies in the same industry are more expensive than MYPS, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.02. MYPS is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 32

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MYPS is valued cheaper than 86.84% of the companies in the same industry.
MYPS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MYPS is cheaper than 86.84% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.16
EV/EBITDA 3.64

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MYPS's earnings are expected to grow with 34.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.79%
EPS Next 3Y34.22%

0

5. Dividend

5.1 Amount

No dividends for MYPS!.
Industry RankSector Rank
Dividend Yield N/A

PLAYSTUDIOS INC

NASDAQ:MYPS (7/1/2024, 7:00:02 PM)

After market: 2.05 0 (0%)

2.05

-0.02 (-0.97%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap276.34M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 32
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.86%
ROE -6.03%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 74.98%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.53
Quick Ratio 4.53
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-750%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y116.59%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)2.87%
Revenue growth 3Y4.83%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y